Infinity China

Portfolio · 3

NovaSight

Eye-Tracking Based Solutions for Pediatric Vision Care

Led ★ 1 round $5.0M committed Latest: 2024-03

Newsight Imaging

CMOS Image Sensor Chips for Machine Vision and Spectral Analysis

1 round $5.0M committed Latest: 2019-10

IOPtima

Surgical Ophthalmic Laser Devices and Accessories

1 round $7.2M committed Latest: 2015-11

Investment activity

1 portfolio exit on record.

Q&A

What is Infinity China's primary investment focus by sector?

Infinity China shows a strong focus on Health Tech & Life Sciences, with two portfolio companies in this sector and one exit. They also have one portfolio company in Industrial Technologies.

Can you name a notable exit for Infinity China?

In September 2018, Infinity China saw an exit with IOPtima, which was acquired by Chengdu Kanghong Pharmaceutical Group for $56M. IOPtima develops surgical ophthalmic laser devices.

Which portfolio companies has Infinity China invested in recently?

Infinity China has invested in NovaSight, which raised an A round of $38.88M, and Newsight Imaging, which raised an A round of $14.1M. Both companies were founded in 2016.

What is the typical funding stage for Infinity China's investments?

Infinity China has participated in one A Round and two B Rounds, indicating a focus on early to growth-stage investments.

What is Infinity China's investment activity trend over time?

Infinity China has shown consistent investment activity, with one new portfolio company added in November 2015, another in October 2019, and the most recent in March 2024.

What is the business model of Infinity China's portfolio company, NovaSight?

NovaSight, a portfolio company of Infinity China, operates with B2B, B2B2C, and B2C business models, focusing on eye-tracking based solutions for pediatric vision care.